Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Bernal, Dr.
Hospital Universitario de Fuenlabrada
Principal Investigator - Guillermo Soria Fernández-Llamazares, Dr
Hospital Universitario de Fuenlabrada
Study Chair - José Sanz Moreno, Dr
Hospital Universitario Príncipe de Asturias
Principal Investigator - Ángela Cano Yuste, Dr
Hospital Universitario Reina Sofia de Cordoba
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Príncipe de Asturias
Alcalá de Henares, Madrid, Spain
José Sanz Moreno, DrRecruiting - Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid, Spain
Recruiting - Hospital Universitario Reina Sofía
Córdoba, Spain
Ángela Cano Yuste, DrRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Oct 2024
- Primary completion
- 2 Oct 2026
- Completion
- 2 Oct 2026
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 50
- Registry id
- NCT06684379
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.